ESR1 and cancer: Globally, breast cancer is the most frequent cancer among women and also the most frequent malignancy overall impacting 2.26 million cases annually [1].In approximately 70% of primary breast cancer, the tumor is estrogen- receptor positive (ER+) and is dependent on estrogen for its proliferation [2].